HK-listed drug discovery firm Viva Biotech rises on debut

VIVA Biotech Holdings

09/05/2019 03:34

** Shares of integrated drug discovery platform operator
Viva Biotech Holdings  1873.HK  trade above their IPO price on
first day of trading, outpacing a fall in the broader market
    ** The stock trades as high as HK$4.67 per share on debut,
around 5.9 pct above the IPO price of HK$4.41 apiece 
    ** Stock ranks the 6th most-traded share in early trade 
    ** Co sells 345 million shares at HK$4.41 apiece, raising
HK$1.37 billion ($174.6 million); net proceeds to add more
biotechnology startups to its incubation portfolio, and to build
up manufacturing capabilities https://bit.ly/2Yf3kK3    
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
slides 0.9 pct, and the benchmark index  .HSI  falls 1.2 pct
    
($1 = 7.8485 Hong Kong dollars)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)